As this hypertension is effectively cured by treatment with thiazide diuretics, hyperactivation of the Na-Cl cotransporter (NCC), the target of thiazide diuretics, is thought to be the main cause of PHAII hypertensive symptoms. The gene discussed is SLC12A3; the disease is pseudohypoaldosteronism type 2.